ArticleOPEN ACCESS

Autoantibody targeting therapies in post COVID syndrome and myalgic encephalomyelitis/chronic fatigue syndrome

Expert Opinion on Biological Therapy
DOI: 10.1080/14712598.2025.2492774
3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Wohlrab, F., Eltity, M., Ufer, F., Paul, F., Scheibenbogen, C., & Bellmann-Strobl, J. (2025). Autoantibody targeting therapies in post COVID syndrome and myalgic encephalomyelitis/chronic fatigue syndrome. Expert Opinion on Biological Therapy. Taylor and Francis Ltd. https://doi.org/10.1080/14712598.2025.2492774

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free